Psychiatr. praxi 2019; 20(3): 108-110 | DOI: 10.36290/psy.2019.024

News in gerontopsychiatry

MUDr. Martina Zvěřová, Ph.D.
Psychiatrická klinika, 1. lékařská fakulta, Univerzita Karlova v Praze a Všeobecná fakultní nemocnice v Praze

There is an intensive research and development of therapeutic procedures and new drugs in all medical fields, also in gerontopsychiatry,
thanks to the new and more accessible technologies as well. A basic overview of the news in gerontopsychiatry is presented.

Keywords: gerontopsychiatry, delirium, dementia, biomarkers

Published: October 11, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zvěřová M. News in gerontopsychiatry. Psychiatr. praxi. 2019;20(3):108-110. doi: 10.36290/psy.2019.024.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Jirák R, et al. Gerontopsychiatrie. Galén, 2013.
    2. Káňová M, Burda M, Povová J, Neiser J. Delirium u kriticky nemocných - prospektivní studie. Cesk Slov Neurol N 2015; 78/111(6): 662-667.
    3. Han JH, Shintani A, Eden S, Morandi A, Solberg LM, Schnelle J, Dittus RS, Storrow AB, Ely EW. Delirium in the emergency department: an independent predictor of death within 6 months. Ann Emerg Med. 2010; 56(3): 244-252. Go to original source...
    4. Boettger S, Jenewein J, Breitbart W. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects. Palliat Support Care. 2015;13:1079-1085. [PubMed]. Go to original source...
    5. Kletečka J, Soumar K, Beneš J. Kognitivní poruchy v perioperační a intenzivní péči Anest. intenziv. Med., 28, 2017, č. 5, s. 297-304.
    6. World Health Organization 2016. World Alzheimer Report 2016: Improving healthcare for people living with dementia: Coverage, quality and costs now and in the future [online]. [cit. 2017-05-22]. Dostupné z WWW: http://www.who.int/mediacentre/factsheets/fs362/en/.
    7. Alzheimer's Association. Alzheimer's Association Report. 2017 Alzheimer's disease facts and figures. Alzheimer's & Dementia, 2017, 13, 4, s. 325-373. Go to original source...
    8. Itzhaki RF, et al. Microbes and Alzheimer's Disease, Journ of Alzheim Dis 2016;51(4): 979-984. Go to original source... Go to PubMed...
    9. Kumar DKV, Eimer WA, Tanzi RE, Moir RD. Alzheimer's disease: the potential therapeutic role of the natural antibiotic amyloid-? peptide. Neurodegener., DiS. Manag. 6(5), 345-348 (2016). Go to original source...
    10. http://www.alzforum.org/news/research-news/does-soluble-trem2-rile-microglia Retrieved 27. 2. 2017.
    11. de la Rubia O, et al. Impact of the Relationship of Stress and the Immune System in the Appearance of Alzheimer's Disease. Journ of Alzheim, DiS. 2017; 55(3): 899-903. Go to original source...
    12. Dronse J, et al. In vivo patterns of Tau pathology, amyloid-B burden, and neuronal dysfunczion in clinical variants of Alzheimer's disease. Journ of Alzhem, DiS. 2017; 55(2): 465-471. Go to original source...
    13. Qizilbash N, et al. BMI and risk of dementia in two million people over two decades: a retrospective cohort study The Lancet Diabetes & Endocrinology. 2015; 3 (6): 431 - 436. Go to original source... Go to PubMed...
    14. Harvard Aging Brain Study 2015.
    15. Hsu DC, et al. Lower Late-Life Body-Mass Index is Associated with Higher Cortical Amyloid Burden in Clinically Normal Elderly. Journ of Alzheim, DiS. 2016; 53(3): 1097-1105. Go to original source... Go to PubMed...
    16. Fung CT, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci. 2017 Feb;20(2):145-155. doi: 10.1038/nn.4476. Epub 2017 Jan 16. Go to original source... Go to PubMed...
    17. Hroudová J. Výzkum nových léčiv Alzheimerovy choroby. Psychiatr. praxi 2017; 18(1): 7-10. Go to original source...
    18. Zvěřová, M. Alzheimer's disease and blood-based biomarkers - potential contexts of use. Neuropsychiatric Disease and Treatment. 2018; 14:1877-1882. Go to original source... Go to PubMed...
    19. Scarr E, Millan MJ, Bahn S, Bertolino A, Turck CW, Kapur S, Möller HJ, Dean B. Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank. Int J Neuropsychopharmacol. 2015 Apr 21; 18(10):pyv042. Epub 2015 Apr 21. Go to original source...
    20. Ashby-Mitchell K, Burns R, Shaw J, Anstey KJ. Proportion of dementia in Australia explained by common modifiable risk factors. Alzheimers Res Ther. 2017;9(1):11. Published 2017 Feb 17. doi:10.1186/s13195-017-0238-x Go to original source...
    21. Etgen T, Sander D, Huntgeburth U, Poppert H, Förstl H, Bickel H. Physical Activity and Incident Cognitive Impairment in Elderly Persons: The INVADE Study. Arch Intern Med. 2010;170(2):186-193. doi:10.1001/archinternmed.2009. 498 Go to original source... Go to PubMed...
    22. Jacka FN, Cherbuin N, Anstey KJ, et al. (2015). Western diet is associated with a smaller hippocampus: a longitudinal investigation. BMC medicine, 13, 215. doi:10.1186/s12916-015-0461-x Go to original source... Go to PubMed...
    23. Podpořeno programovými projekty Ministerstva zdravotnictví ČR s reg. č. 15-28616 A a reg. č. 15-28967 A a grantovými projekty Grantové agentury ČR s reg. č. 17-07585Y a reg. č. 17-05292S.

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.